Skip to main content
Home > Week in Review > Sales & Marketing

Chronological Index of : Sales and Marketing

 Current Issue
  • Daiichi Sankyo sales and marketing update

    Daiichi Sankyo Co. Ltd. (Tokyo:4568), Tokyo, Japan Business: Cardiovascular The U.K.s NICE issued final guidance recommending Lixiana edoxaban from Daiichi to prevent stroke and systemic embolism in adults with non-…

    Published on 10/12/2015
  • Gilead sales and marketing update

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Business: Cancer The U.K.s NICE issued final draft guidance recommending Zydelig idelalisib from Gilead to treat chronic lymphocytic leukemia (CLL). The product is…

    Published on 10/12/2015
  • Novartis sales and marketing update

    Novartis AG (NYSE:NVS;SIX:NOVN), Basel, Switzerland Business: Pharmaceuticals, Generics Novartis launched Novartis Access, a portfolio of 15 products, in Ethiopia, Kenya and Vietnam. The 15 products include patented and…

    Published on 10/12/2015
  • Opko, Tesaro sales and marketing update

    Opko Health Inc. (NYSE:OPK; Tel Aviv:OPK), Miami, Fla. Tesaro Inc. (NASDAQ:TSRO), Waltham, Mass. Business: Gastrointestinal The National Comprehensive Cancer Network (NCCN) will include Varubi rolapitant from Tesaro in …

    Published on 10/12/2015
  • Roche sales and marketing update

    Roche (SIX:ROG;OTCQX:RHHBY), Basel, Switzerland Business: Diagnostic Roche launched the cobas EGFR Mutation Test v2 in countries that accept CE Mark as a companion diagnostic to select non-small cell lung cancer (NSCLC)…

    Published on 10/12/2015
  • Santhera sales and marketing update

    Santhera Pharmaceuticals Holding AG (SIX:SANN), Liestal, Switzerland Business: Ophthalmic Santhera launched Raxone idebenone in Germany to treat Lebers Hereditary Optic Neuropathy (LHON). The company declined to …

    Published on 10/12/2015
  • SciVac sales and marketing update

    SciVac Therapeutics Inc. (TSX:VAC, OTCQX:SVACF), Rehovot, Israel Business: Infectious SciVac resumed manufacturing and sales of Sci-B-Vac in Israel. The company issued a recall in July after it found that packages of …

    Published on 10/12/2015
  • Siemens sales and marketing update

    Siemens AG (Xetra:SIE; NYSE:SI), Munich, Germany Business: Diagnostic The U.K.s NICE issued guidance recommending Siemens Virtual Touch Quantification (VTq) to diagnose liver fibrosis in patients with chronic HBV or HCV…

    Published on 10/12/2015
  • Taiho sales and marketing update

    Taiho Pharmaceutical Co. Ltd., Tokyo, Japan Business: Cancer Taiho launched Taiho Oncology Patient Support, an access program in the U.S. for Lonsurf trifluridine/tipiracil. The access program includes a co-pay card, …

    Published on 10/12/2015
  • Veritas sales and marketing update

    Veritas Genetics, Danvers, Mass. Business: Genomics Veritas partnered with the Personal Genome Project to launch whole genome sequencing and interpretation services for project participants for $999. The company said …

    Published on 10/12/2015
  • Aegerion sales and marketing update

    Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR), Cambridge, Mass. Business: Endocrine/Metabolic The German Institute for Quality and Efficiency in Health Care (IQWiG) said in an early benefit assessment that Lojuxta …

    Published on 10/5/2015
  • BioSpecifics, Endo, Swedish Orphan Biovitrum sales and marketing update

    BioSpecifics Technologies Corp. (NASDAQ:BSTC), Lynbrook, N.Y. Endo International plc (NASDAQ:ENDP; TSX:ENL), Dublin, Ireland Swedish Orphan Biovitrum AB (SSE:SOBI), Stockholm, Sweden Business: Musculoskeletal NICE …

    Published on 10/5/2015
  • Celgene sales and marketing update

    Celgene Corp. (NASDAQ:CELG), Summit, N.J. Business:Cancer The U.K.s NICE issued final draft guidance recommending against Abraxane nab-paclitaxel to treat pancreatic cancer in combination with gemcitabine. The agency …

    Published on 10/5/2015
  • Chugai, Roche sales and marketing update

    Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Autoimmune The U.K.s NICE issued a final appraisal determination (FAD) recommending RoActemra …

    Published on 10/5/2015
  • Clinigen Group, Neuraltus sales and marketing update

    Clinigen Group plc (LSE:CLIN), Burton-on-Trent, U.K. Neuraltus Pharmaceuticals Inc., Palo Alto, Calif. Business: Neurology The companies launched a managed access program in Europe for Neuraltus NP001 to treat …

    Published on 10/5/2015
  • Eli Lilly sales and marketing update

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Cancer The U.K.s NICE issued preliminary draft recommending against Cyramza ramucirumab from Eli Lilly to treat advanced gastric cancer or gastro-esophageal …

    Published on 10/5/2015
  • Eli Lilly, Sumitomo Dainippon sales and marketing update

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Sumitomo Dainippon Pharma Co. Ltd. (Tokyo:4506), Osaka, Japan Business: Endocrine/Metabolic Eli Lilly and Sumitomo Dainippon launched Trulicity dulaglutide in Japan to …

    Published on 10/5/2015
  • Foundation Medicine sales and marketing update

    Foundation Medicine Inc. (NASDAQ:FMI), Cambridge, Mass. Business: Genomics Foundation launched GeneKit for interpreting and reporting genomic information to inform therapeutic decisions for cancer. The cloud-based …

    Published on 10/5/2015
  • MDxHealth sales and marketing update

    MDxHealth S.A. (Euronext:MDXH), Liege, Belgium Business: Diagnostic Tufts Health Plan will cover MDxHealths ConfirmMDx for Prostate Cancer test. MDxHealth markets the epigenetic laboratory-developed test (LDT) to assess…

    Published on 10/5/2015
  • Acura, Egalet sales and marketing update

    Acura Pharmaceuticals Inc. (NASDAQ:ACUR), Palatine, Ill. Egalet Corp. (NASDAQ:EGLT), Wayne, Pa. Business: Neurology Egalet launched Oxaydo oxycodone in the U.S. for managing acute and chronic moderate to severe pain. …

    Published on 9/28/2015
  • Boehringer Ingelheim sales and marketing update

    Boehringer Ingelheim GmbH, Ingelheim, Germany Business: Pulmonary The U.K.s NICE issued preliminary draft guidance recommending Ofev nintedanib from Boehringer to treat idiopathic pulmonary fibrosis (IPF) -- its …

    Published on 9/28/2015
  • Helsinn, Chugai sales and marketing update

    Helsinn Healthcare S.A., Lugano, Switzerland Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Business: Gastrointestinal Chugai launched Akynzeo netupitant/palonosetron in the U.K. to prevent chemotherapy-…

    Published on 9/28/2015
  • Merck sales and marketing update

    Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Business: Cancer The U.K.s NICE issued a final appraisal determination (FAD) recommending Keytruda pembrolizumab to treat unresectable or metastatic melanoma in patients …

    Published on 9/28/2015
  • NanoString sales and marketing update

    NanoString Technologies Inc. (NASDAQ:NSTG), Seattle, Wash. Business: Functional genomics NanoString launched nCounter RNA:Protein PanCancer Immune Profiling Panel for gene and protein expression analysis in cancer. The …

    Published on 9/28/2015
  • Novo Nordisk sales and marketing update

    Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Business: Endocrine/Metabolic The German Institute for Quality and Efficiency in Health Care (IQWiG) said data from Novo Nordisk supporting Xultophy insulin …

    Published on 9/28/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993